Brief: Polyphor Presents New In-Vivo Efficacy And Tolerability Data

Spexis AG

07/06/2019 06:02

June 7 (Reuters) - Polyphor AG  POLN.S :
    * POLYPHOR PRESENTS NEW IN-VIVO EFFICACY AND TOLERABILITY
DATA FOR
A POTENTIAL INHALED ADMINISTRATION OF ITS LEAD ANTIBIOTIC
MUREPAVADIN AT EUROPEAN CYSTIC FIBROSIS CONFERENCE

Source text for Eikon:  ID:nEQblgzxda 
Further company coverage:  POLN.S 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))